EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers

EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers

Abstract Arcagen (NCT02834884) is a European prospective study aiming at defining the molecular landscape of rare cancers for treatment guidance. We present data from the cohort of rare thoracic tumors. Patients with advanced pleural mesothelioma (PM) or thymic epithelial tumors (TET) underwent geno...

Full description

Bibliographic Details
Main Authors:	Marco Tagliamento, Marie Morfouace, Charalambos Loizides, Julio Oliveira, Laurent Greillier, Judith Raimbourg, Anne-Claire Toffart, Thierry Chatellier, Nicolas Cloarec, Ivana Sullivan, Birute Brasiuniene, Michael Duruisseaux, Kersti Oselin, Marie-Sophie Robert, Carolina Fernandes, Arnaud Poncin, Jean-Yves Blay, Benjamin Besse, Nicolas Girard
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-02-01
Series:	npj Precision Oncology
Online Access:	https://doi.org/10.1038/s41698-024-00518-9

Similar Items

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN
by: Oliver Holmes, et al.
Published: (2020-12-01)

The Problematic of Embodiment in Online Specta(c)torship
by: Mihai Băcăran
Published: (2023-05-01)

Novel SPECTA Actuator to Improve Energy Recuperation and Efficiency
by: Elias Saerens, et al.
Published: (2022-02-01)

From bench to clinical trials the EORTC experience in biology-based clinical cancer research
by: Konstantinos Tryfonidis, et al.
Published: (2017-12-01)

THE EORTC AND THE EORTC BREAST CANCER GROUP
by: Therasse Patrick
Published: (2005-01-01)

Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
by: Ali Chour, et al.
Published: (2024-09-01)

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform
by: M. Morfouace, et al.
Published: (2022-05-01)

An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26
by: Juan Ignacio Arraras, et al.
Published: (2024-10-01)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
by: Khoshnevisan Alireza, et al.
Published: (2012-05-01)

Health Care Resource Use at End of Life in Patients with Advanced Lung Cancer
by: Kersti Oselin, et al.
Published: (2021-10-01)

Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer
by: Kersti Oselin, et al.
Published: (2021-03-01)

Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer
by: Fernanda Alessandra Silva Michels, et al.
Published: (2013-06-01)

Phase 1–3 of the cross‐cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ‐22
by: Anne Sophie Oberguggenberger, et al.
Published: (2018-03-01)

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
by: Monika Sztankay, et al.
Published: (2018-11-01)

Distress Response to the Failure to an Insoluble Anagrams Task: Maladaptive Emotion Regulation Strategies in Binge Drinking Students
by: Marie Poncin, et al.
Published: (2017-10-01)

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
by: Axel Le Cesne, et al.
Published: (2019-08-01)

EORTC - CNRS – Colóquio Internacional sobre Neoplasmas Linfóides.
by: G. T. O'Conor, et al.
Published: (2023-08-01)

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30
by: Helen McTaggart-Cowan, et al.
Published: (2019-04-01)

Comparing the contents of patient-reported outcome measures for fatigue: EORTC CAT Core, EORTC QLQ-C30, EORTC QLQ-FA12, FACIT, PRO-CTCAE, PROMIS, Brief Fatigue Inventory, Multidimensional Fatigue Inventory, and Piper Fatigue Scale
by: Maria Rothmund, et al.
Published: (2024-12-01)

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
by: Morgane Denis, et al.
Published: (2020-03-01)

The communication between cancer patients and professionals. The EORTC communication questionnaire
by: Juan Ignacio Arraras, et al.
Published: (2017-05-01)

Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
by: Zhang J, et al.
Published: (2014-09-01)

The process of forward-backward translation of the EORTC QLQ-SWB into Persian
by: Sepideh Omidvari, et al.
Published: (2014-12-01)

Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires
by: Ficko Sanja Ledinski, et al.
Published: (2019-09-01)

Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group
by: Frédéric Baron, et al.
Published: (2012-04-01)

Associations between the spiritual well-being (EORTC QLQ-SWB32) and quality of life (EORTC QLQ-C30) of patients receiving palliative care for cancer in Cyprus
by: Maria Kyranou, et al.
Published: (2021-08-01)

The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables
by: J Fernandez-Gomez, et al.
Published: (2011-10-01)

Outcomes of Treatment for Melanoma Brain Metastases
by: Mantas Janavicius, et al.
Published: (2020-01-01)

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension
by: Rūta Everatt, et al.
Published: (2025-01-01)

Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study
by: Rūta Everatt, et al.
Published: (2024-03-01)

P1683: THE EORTC QLQ-HL27: EORTC PROSPECTIVE INTERNATIONAL VALIDATION OF A DISEASE-SPECIFIC QUESTIONNAIRE FOR ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HODGKIN LYMPHOMA
by: Simone Oerlemans, et al.
Published: (2023-08-01)

EORTC-CLTG 2022: Vital Platform to Discuss the Recent Advances in Cutaneous Lymphomas
by: Emmanuella Guenova
Published: (2022-10-01)

Quality of Life Assessment with EORTC QLQ in Patients with Multiple Myeloma: Multicenter Study
by: Ali İhsan GEMİCİ, et al.
Published: (2022-08-01)

Normative data for the EORTC QLQ-C30 from the Austrian general population
by: Jens Lehmann, et al.
Published: (2020-08-01)

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program
by: Charline Lasnon, et al.
Published: (2017-05-01)

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
by: Kaminsky Marie-Christine, et al.
Published: (2011-08-01)

Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I
by: L. Wintner, et al.
Published: (2022-06-01)

Translation and adaptation of the EORTC QLQ-LC 29 for use in Chinese patients with lung cancer
by: Wei Dai, et al.
Published: (2021-11-01)

Translation and validation of the EORTC QLQ-BR45 among Ethiopian breast cancer patients
by: Mikiyas Amare Getu, et al.
Published: (2022-07-01)

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
by: Eva M. Gamper, et al.
Published: (2021-10-01)